<DOC>
	<DOCNO>NCT00714090</DOCNO>
	<brief_summary>The purpose study assess efficacy add-on therapy repetitive Transcranial Magnetic Stimulation ( rTMS ) venlafaxine treatment major depressive disorder compare venlafaxine ( optimal medication ) rTMS .</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation Venlafaxine Depression</brief_title>
	<detailed_description>rTMS parameter : Intensity 120 % individually determine motor threshold ; frequency : 1 Hz ; 360 impulsion ; period : 1 min ; period : 30 .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Adults Clinical diagnosis major depressive disorder ( DSMIV ) HDRS17 item &gt; 20 Failure one antidepressant treatment ( efficacious dose 6 week least ) I II bipolar disorder Psychotic feature Failure one previous venlafaxine treatment Addiction comorbidity schizophrenia comorbidity Involuntary hospitalization Seizures history Pregnancy breastfeed Somatic comorbidity able impact cognitive function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>repetitive Transcranial Magnetic Stimulation ( rTMS )</keyword>
	<keyword>Major depressive disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Venlafaxine</keyword>
</DOC>